The CADENCE trial showed that sotatercept reduced pulmonary vascular resistance and improved right ventricular function in CPC-PH.
Ryan Tedford, MD
Advertisement
Articles by Ryan Tedford, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Early Recognition and Routine Discussion: Improving Outcomes in Tardive Dyskinesia
2
Do GLP-1 Receptor Agonists Increase the Risk of Smell and Taste Disturbances?
3
Melatonin May Reduce Musculoskeletal Pain and Improve Sleep
4
Meet the FDA’s Newly Approved OTC Sunscreen Ingredient: Bemotrizinol
5